As a consequence of modern drug discovery techniques, lipid-based drug delivery systems are the most popular approaches usually used to improve the dissolution and oral bioavailability of hydrophobic drugs. Self-emulsifying drug delivery systems (SEDDS), as one class of these lipidbased systems, are isotropic mixtures of oil, surfactants and co-surfactants where the drug is usually better soluble than in oil alone. The principal characteristic of SEDDS is their ability to form fine oil in water micro-emulsifying drug delivery systems (MEDDS) upon dilution by an aqueous phase through the gastrointestinal tract. SEDDS are considered promising strategy to improve the rate and extent of oral absorption of drugs. However conventional liquid SEDDS have some limitations, solid SEDDS are prepared by solidification of liquid self-emulsifying ingredients into powders or nanoparticles. This overview gives a particular emphasis on the solidification techniques and applications of liquid SEDDS in the pharmaceutical dosage forms to meet a wide range of the formulation requirements achieving reasonable routes of administration with efficient oral bioavailability.
INTRODUCTION
Low oral bioavailability of drugs as a consequence of their low water solubility is a growing challenge to the development of new pharmaceutical products. One of the most popular approaches of oral bioavailability and solubility enhancement is the utilization of lipid-based drug delivery systems. Their use in product development is growing due to the versatility of pharmaceutical lipid excipients and drug formulations, and their compatibility with liquid, semi-solid and solid dosage forms (Cerpnjak et al., 2013).
In fact, the most popular approach is the incorporation of the drug compound into inert lipid vehicles such as oils, surfactant dispersions Self-emulsifying drug delivery systems (SEDDS) are thermodynamically stable, isotropically clear dispersions of oils stabilized by an interfacial film of surfactant molecules. The surfactant may be pure or combined with other additives such as cosurfactants. One characteristic of these systems is their ability to form fine oil-inwater (O/W) micro-emulsifying drug delivery systems (MEDDS) upon mild agitation when exposed to aqueous media ( Figure 1 ). In addition, these systems are recently being used for improving the dissolution and absorption of lipophilic drugs 
Figure (1): Schematic diagram of SEDDS and MEDDS
Self-emulsifying drug delivery systems, as an approach to improve the bioavailability of drugs, have many advantages such as:
 Where, hydrophobic drugs can often be dissolved in SEDDS allowing them to be encapsulated as unit dosage forms for peroral administration (Pouton, 2000) .  When such a formulation is released into the lumen of gastrointestinal tract (GIT), it disperses to form a fine emulsion of small droplet size (<5 µm) with the aid of gastrointestinal (GI) fluids. This leads to in-situ solubilization of the drug that can subsequently be absorbed by lymphatic pathways, bypassing the hepatic first pass metabolism (Kohli et al., 2010).  For drugs subject to dissolution ratelimited absorption, SEDDSs may offer an improvement in both rate and extent of the drug absorption and the reproducibility of plasma concentration profiles ( . To address these problems, solid SEDDS have been investigated as an alternative approach. These solid systems require the solidification of liquid self-emulsifying (SE) ingredients into powders or nanoparticles which can be converted to various solid dosage forms. Thus, solid SEDDS have combined advantages of liquid SEDDS with those of solid dosage forms such as economical production, convenience of process control and higher stability, reproducibility and patient compliance (Czajkowska-Kosnik et al., 2015).
Components of SEDDS
Gursoy and Benita, 2004 reported that self-emulsification has been shown to be specific to: the nature of the oil-surfactant pair, the surfactant concentration, oilsurfactant ratio and the temperature at which self-emulsification occurs. Detailed list of the most popular excipients used in the SEDDS preparation for oral administration has been illustrated by Hauss, 2007 as follows:
Drug candidates
The use of SEDDS can be extended to solve the problems of all four drug categories of Biopharmaceutical Classification System (BCS) ( 
Oils
The oil represents one of the most important excipients in the SEDDS formulation. Not only because it can solubilize marked amounts of the lipophilic drug or facilitate self-emulsification, but also it can increase the fraction of the lipophilic drug transported via the intestinal lymphatic system, thereby increasing the absorption of drug from the GIT. It also influences the SE ability of the formulation and drug precipitation in GIT (Cerpnjak et al., 2013).
Examples of oils that may be used in the preparation of SEDDS are represented in Table ( 2). Long-chain triglycerides (natural edible oils) are not frequently preferred in SEDDS formulation owing to their poor ability to dissolve large amounts of lipophilic drugs.
While, medium-chain mixed glycerides have become popular excipients having even greater solvent capacity and enhanced ability to promote emulsification and lack of susceptibility to oxidation (Porter et al., 2004) .
Surfactants
In the context of oral lipid-based formulations, the surfactant is obligatory to provide the essential emulsifying characteristics to SEDDS. Surfactants of intermediate hydrophilic-lipophilic balance (HLB) (8-12) which adsorb strongly at oilwater (O/W) interfaces are called 'water insoluble surfactants'. These materials are insufficiently hydrophilic to dissolve in water and form micelles, but nevertheless are sufficiently hydrophilic to be capable of driving self-emulsification. These surfactants are sometimes described as 'dispersible' in water, meaning that they can form an emulsion if subject to shear. These materials typically are predominantly oleate esters such as Tween 85 (Zhang et al., 2015) .
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surfactants' as shown in Table ( The role of surfactants in SEDDS formulation is to reduce the interfacial tension and adjust the spontaneous curvature of the interface. This enables the dispersion process and provides the formation of a flexible film that can easily cover the lipid core of the emulsion droplets. This film can lead to spontaneous formation of a microemulsion ( Figure 2 ) (Müllertz et al., 2010).
Figure (2): Composition of SEDDS
Safety is a major determining factor in choosing a surfactant. Non-ionic surfactants are often used in pharmaceutical applications and SEDDS formulations because of their lower toxicity. They have greater stability towards the changes in the ionic strength and pH that are likely to be encountered in the biological environment (Zhang et al., 2015) .
Usually the surfactant concentration ranges between 30 and 60% w/w in order to form stable SEDDS. It is very important to determine the surfactant concentration properly because large amounts of surfactants may lead to reversible changes in the permeability of the intestinal lumen (Gursoy and Benita, 2004).
Co-surfactants
It has been assumed that co-surfactants can be included to improve the solubility of the drug in SEDDS and increase the solvent capacity of the formulation for drugs which dissolve freely in the co-surfactants. To enhance the solvent capacity, the cosurfactant must be presented at high concentration (generally more than 30% w/w). This may constitute a problem since the polar co-surfactant will partition into the aqueous phase and reduce the solubilization capacity of the dispersed system resulting in precipitation of the drug compound (Pouton and Porter, 2008; Müllertz et al., 2010). Examples of commonly used co-surfactants are represented in Table ( 2).
Polymers
Inert polymers representing from 5 to 40% w/w of the composition are capable of forming a matrix used in the formulation of sustained release SEDDS preparations 
Overview of SEDDS formation and phase behavior 1. Theory of SEDSS formation
According to Reiss, 1975, selfemulsification occurs when the entropy change that favors dispersion is greater than the energy required to increase the surface area of the dispersion. The free energy of the conventional emulsion can express the formation of new surface between the oil and water phases. This can be described by the following equation:
DG = Σ N π r 2σ
Where, DG: the free energy associated with the process (ignoring the free energy of mixing), N: the number of droplets of radius (r) and σ: the interfacial energy.
Phase behavior
The relationship between the phase behavior of a mixture and its composition can be determined by using the phase diagram. The phase behavior of simple microemulsion systems comprising oil, water and surfactant can be studied using ternary phase diagram in which each corner of the diagram represents 100% of that particular component. The diagram helps to determine the optimum concentration ranges of different excipients necessary to obtain SEDDS.
More commonly, when the microemulsion contains additional components such as a co-surfactant, pseudoternary phase diagrams are used where one corner typically represents a binary mixture of two components such as surfactantcosurfactant mixture (Figure 3 ) (Lawrence and Rees, 2012). Table ( 
The risk of precipitation
The solubility of the drug in oil phase greatly influences the ability of SEDDS in maintaining the drug in solution state. When the drug is solubilized by the use of surfactant or co-surfactant, the dilution of SEDDS formulation with water can lead to lowering the solvent capacity of surfactant or co-surfactant. This may result in precipitation of the drug. This depends on the Log P of the drug and to what extent the surfactant is contributing to drug solubilization within the formulation (Pouton, 2000; Chime et al., 2014).
Emulsion droplet polarity
The emulsion droplet polarity is one of the most important factors in characterizing the emulsification efficiency. Hydrophiliclipophilic balance, chain length, degree of unsaturation of the fatty acid, molecular weight of the hydrophilic portion and concentration of the surfactant have an impact on polarity of the oil droplet. The polarity reflects the affinity of the drug for oil and/or water and the type of forces involved. The high polarity will enhance the drug release into the aqueous phase (Gursoy and Benita, 2004). This is confirmed by Kim et al., 2000 who observed that the release rate of Idebenone from SEDDS was dependent on the polarity of the oil phase used. The highest release was obtained with formulations that had highly polar oily phase. Physicochemical characterization of SEDDS
Percent transmittance
The primary means of self-emulsification assessment is visual evaluation. To avoid any subjective variations, the percent transparency obtained on dilution/reconstitution of the SE formulations is measured using Ultravioletvisible (UV-VIS) spectrophotometer at λ max ranged between 630-650 nm (Gupta et al., 2013).
Droplet size
The droplet size of the emulsion is a crucial factor in self-emulsification performance because it determines the rate and extent of the drug release and absorption. It has been reported that the droplet size distribution is one of the most important characteristics of the in-vivo fate of drug emulsion. The globule size is most commonly measured based on the principle of dynamic light scattering (DLS) or photon correlation spectroscopy (PCS) (Yang et al.,  2004) .
Robustness to dilution
Robustness to dilution is the ability of the emulsion formed to maintain similar properties at different degrees of dilutions in order to achieve uniform drug release profile. Also, it is important to ensure that the drug will not get precipitated at higher dilutions in-vivo which may significantly retard the absorption of the drug from the formulation (Gupta et al., 2013).
Zeta potential
Zeta potential is used to identify the surface charge of the oil droplets which is usually negative due to the presence of free fatty acids (Creţu and Şolea, 2017). Generally, zeta potential helps to predict the stability and flocculation effect in the emulsion systems where a high zeta potential value (more than ± 30 mV) maintains a stable system. If the zeta potential falls below this level, the colloid will aggregate due to the attractive forces (Kosnik et al., 2015).
Determination of self-emulsification time
The rate of self-emulsification is usually determined by adding a dose of the SEDDS (preferably in a capsule) to an amount of water or biorelevant media. By visual observation or by monitoring the change of turbidity in emulsion using a UV-VIS spectrophotometer, the rate of emulsification is determined (Müllertz et al., 2010) . The mechanism of emulsification involves the erosion of a fine cloud of small particles from the surface of large droplets, rather than a progressive reduction in droplet size (Kohli et al., 2010).
Thermodynamic stability studies
The physical stability of the lipid-based formulation is also crucial to its performance which can be adversely affected by precipitation of the drug in the excipient mixture. In addition, poor physical stability can lead to phase separation of the excipients affecting not only the formulation performance, but the visual appearance as well. The three following cycles have been used to examine the stability of the selected SEDDS formulations (Subramanian and Siddalingam, 2017): a) Heating and cooling cycles: Six cycles of cooling and heating between refrigerator temperature (4°C) and elevated temperature (45°C) with exposure at each temperature for not less than 48 hr can be carried out. The formulations, which were stable, were then subjected to centrifugation test. b) Centrifugation:
Formulations that passed the heating and cooling cycles were centrifuged at 15000 rpm for 15 min. Those formulations that did not show any phase separation were taken for the freezing and thawing test. c) Freezing and thawing cycles: Three freezing and thawing cycles between freezing temperature (-18°C) and room temperature (25°C) with storage at each temperature for not less than 48 hr can be performed. Those formulations that passed this test, showed good stability with no phase separation, cracking or creaming.
In-vitro dissolution studies
In-vitro dissolution studies are carried out to study the drug release behavior and to predict the in-vitro assessment of bioavailability. USP dissolution apparatus type II using simulated gastric fluid (pH 1.2) maintained at a temperature of 37 ± 0.5ºC is usually used (Khedekar and Mittal, 2013). The carriers should be selected for their ability to adsorb a great quantity of liquid excipients achieving high drug loading, high lipid exposure and good flowability of the mixture after adsorption. The resulting free flowing powder may then be filled directly into capsules or alternatively mixed with suitable excipients before compression into tablets (Shrestha et al., 2014) . A significant benefit of the adsorption technique is the good content uniformity and the possibility for high lipid exposure of SEDDS (up to 70% w/w) adsorbed onto suitable carriers (Jannin et al., 2008).
An alternative method of solid SEDDS preparation was adopted by Agarwal et al., 2013 in their study. Where, the powdered SE lipid formulation of meloxicam was obtained by simple trituration of liquid SEDDS with a solid adsorbent (mixture of silicon dioxide and magnesium aluminum silicate 1:1) until a homogenous blend was formed. The powdered SEDDS formulation showed higher bioavailability in beagle dogs when compared with that of commercially available tablets. In another study, solid SEDDS of fenofibrate was formulated by solidification of the molten solution of the oily phase, surfactant, co-surfactant and drug mixture with PEG 6000 polymer. Where, the solid SEDDS formulation with 10% w/w fenofibrate loading showed as much as 20-fold increase in the dissolution profile (Kanaujia et al., 2014) .
On the other hand, Kang et al., 2011 pointed out that strong adsorption and physical interaction of the drug with the carriers may cause retarded or incomplete release of the drug from the solid SEDDS formulations.
Melt granulation
Melt granulation or pelletization is a single step-process that allows the transformation of the powder mixture containing the SE liquid drug into granules or spheronized pellets. This technique necessitates a high shear mixing with a presence of a meltable binder which may be sprayed in molten state onto the powder mixture. The melted binder forms liquid bridges with the powder particles which can be shaped into small agglomerates and transformed to spheronized pellets (Shrestha et al., 2014) . The main parameters that control the granulation process are the impeller speed, mixing time, binder particle size and viscosity of the binder (Seo and Schaefer, 2001) .
A wide range of solid and semisolid lipids can be applied as meltable binders such as Gelucire ® that is able to increase the dissolution rate of drugs owing to its SE property (Seo et al., 2003) . Also, the melt granulation process may be used for adsorbing SE systems on solid neutral carriers such as Neusilin ® US 2 (Gupta et al., 2002).
Melt extrusion/extrusion spheronization
Extrusion is a process of converting the raw material with plastic properties into a product of uniform shape and density. This can be achieved by forcing it through a die under controlled temperature, product flow and pressure conditions. Melt extrusion is a solvent-free process that allows high drug loading as well as content uniformity (Breitenbach, 2002 
Self-emulsifying capsules
After oral administration of the conventional liquid SE formulations in form of capsules, microemulsion droplets are formed and subsequently disperse in the GI tract to reach the sites of absorption. However, if the irreversible phase separation of the microemulsion occurs, an improvement of drug absorption cannot be expected (Itoh et al., 2002) . The SEDDS can be designed using a small quantity of polymers such as HPMC in the formulation to prevent precipitation of the drug by generating and maintaining a supersaturated state in-vivo. This system contains a reduced amount of surfactant, thereby minimizing the GI side effects (Gao et al., 2003) .
Ansari et al., 2014 developed an efficient and convenient SE system of felodipine where the SEDDS formulations were filled in hard gelatin capsules due to their anhydrous nature enabling the administration of the drug as unit dosage form. The hard gelatin capsules were coated with a polymer in order to achieve a rapid drug release after a desired time lag in the management of hypertension. In another study, to enhance the solubility and permeability of hydrochlorothiazide via SEDDS, the SEDDS formulation was transformed into a free flowing powder and non-effervescent floating capsules containing solid SEDDS of the drug were prepared (Jagdale and Phargade, 2017). In addition, oral administration of SE capsules solidified using different kinds of adsorbents has been found to enhance patient compliance compared with the parenteral route (Ito et al., 2006) .
Self-emulsifying sustained/controlled release tablets
The SE tablets consist of solidified liquid SEDDS either compressed or molded into tablets. These preparations offer many advantages because these tablets can liquify at body temperature under agitation due to the peristaltic movement of GIT that will lower the liquification time, resulting in faster emulsification with increased drug plasma concentration (Wagh et al., 2014) .
In 
Self-emulsifying sustained/controlled release pellets
Although the application of SEDDS is primarily intended for improvement of the absorption of poorly water soluble drugs, it would also be desirable to provide sustained release action in the case of drugs having short biological half-life with low and frequent dosing. For this reason, the combinations of SEDDS with control release agents have been studied in order to develop a matrix type controlled release solid SEDDS. Matrix type spherical pellets of solid SEDDS have been developed offering the benefits of both absorption improvement and sustained release (Zhang et al., 2012) . Thus, it is very appealing to combine the advantages of pellets with those of SEDDS by SE pellets.
Self-emulsifying (SE) pellets as multiple unit dosage forms can be filled easily into capsules or processed into tablets. Due to the spherical shape, smooth surface and narrow size distribution of pellets, SE pellets are particularly suitable for sustained release formulations. These formulations are prepared either by application of a sustained release coating from a polymeric dispersion or solution onto the drug containing pellets, or by employing mixtures of pellets forming powder excipients such as microcrystalline cellulose (MCC) with sustain release agents to form a sustained release matrix (Nikolakakis and Partheniadis, 2017). These excipients are usually gel-forming hydrophilic polymers such as cellulose ethers like HPMC (Liu et la., 2017) and methacrylic acid based polymers like carbopol or colloidal silicon dioxide (Podczeck, 2008) .
Experiments with colloidal silicon dioxide in mixtures with MCC using SEDDS added as emulsions-binders in extrusion/spheronization process showed that good quality pellets can be formed. Therefore, colloidal silicon dioxide serves a multi-purpose; as a pellet forming powder, a strong adsorbent and gelling agent that provides a controlled release of drugs (Patel et al., 2014b; Agrawal et al., 2015).
Self-emulsifying solid dispersions
Self-emulsifying solid dispersions are efficient techniques that successfully improve the solubility and oral bioavailability of many lipophilic drugs with classical polymers or solubilizers (Ansari et al., 2016). Preparation of SE solid dispersions is an economic way to improve wettability, increase surface area, reduce agglomeration and convert the drug to its amorphous state leading to higher rate of solvation (Craig, 2002). Melting method and solvent method are the major conventional techniques employed to prepare SE solid dispersions (Eloy and Marchetti, 2014). Where, the melting method involves the melting and rapid cooling of the drug-polymer mixture to obtain the supersaturation. The solvent method involves the solubilization of the drug and carrier in a common volatile solvent system followed by evaporation.
The key to the success for the previous methods is the conversion of drug to its amorphous form which enjoys higher solubility. Since the amorphous drug in the solid dispersions is thermodynamically unstable and can recrystallize during storage 
Self-emulsifying beads
It was hypothesized that using capillary forces SEDDS can be developed to transform the SE formulation into a solid form with minimum amounts of solidifying aids and avoid leaking and leaching problems of conventional liquid SE formulations. These capillary forces SEDDS can be loaded into the microchannels of preformed porous polystyrene beads (PPB) typically produced by copolymerizing styrene and divinyl benzene ( 
7.
Self-emulsifying sustained-release microspheres
In order to design a sustained-release formulation of an oily drug, the sustainedrelease microspheres with SE capability has been prepared. You et al. 2006 developed sustained-release microspheres containing zedoary turmeric oil by the emulsionsolvent-diffusion method of the spherical crystallization technique in order to improve the bioavailability of the drug. In another study, Li and Yi, 2013 prepared SE microspheres by membrane emulsification technology with the solid carrier in a gel state formed by sodium alginate and calcium chloride.
Self-emulsifying suppositories
Rectal administration is often sought as an alternative route of administration to overcome the gastric irritation, nausea and vomiting that may be associated with oral administration. Furthermore, drugs are administered rectally to achieve ease and safety of administration when the oral route is not convenient as in infants and elderly patients (Cetinkaya, 2012).
Kim and Ku, 2000 examined the SEDDS as a potential vehicle for enhancing the absorption of indomethacin where the SEDDS formulation containing the drug was administered orally or rectally to rats. Where, the area under the curve (AUC 0-12 hr ) increased significantly (41% increase) after rectal administration of gelatin hollow type suppositories filled with SEDDS containing indomethacin to rats. Also, Gugulothu et al., 2010 developed SE suppositories of β-artemether as an alternative dosage form to overcome the gastric irritation, nausea, and vomiting that may be associated with oral administration.
Self-emulsifying ocular delivery systems
Ocular drugs are usually formulated as eye drops in solutions or suspensions. The major problem in ocular therapy is low topical absorption of drugs caused by relative impermeability of cornea and short residence time of the ocular preparation. This problem may result from precorneal events such as tear turnover, tear dilution or blinking. The drug bioavailability from eye drops is typically less than 5%. On the other hand, recommended frequent dosing at high concentration can result in several side ISSN 1110-5089 Vol. 27 
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